Técnica para injeção intravítrea de drogas no tratamento de doenças vítreorretinianas

Related authors

• Eduardo Buchele Rodrigues
• Mauricio Maia
• Fernando Marcondes Penha
• Eduardo Dib
• Arnaldo Furman Bordon
• Octaviano Magalhães Júnior
• Michel Eid Farah

Related articles

• Evaluation of contrast sensitivity in non-high-risk proliferative diabetic retinopathy treated with panretinal photocoagulation with and without intravitreal injections of ranibizumab
• Age-related macular degeneration: a review of current therapies and new treatments
• Changes in the ganglion cell complex thickness after anti-VEGF treatment for diabetic macular edema
• Is there a relationship between the first-day results of anti-VEGF therapy for macular edema due to vascular diseases and longterm outcomes?
• ETDRS panretinal photocoagulation combined with intravitreal ranibizumab versus PASCAL panretinal photocoagulation with intravitreal ranibizumab versus intravitreal ranibizumab alone for the treatment of proliferative diabetic retinopathy
• Three versus five intravitreal aflibercept injections as the initial loading phase in the treatment of diabetic macular edema: one-year results
• Benzoporphyrin (verteporfin) photodynamic therapy for choroidal neovascularization in age-related macular degeneration
• Switch to aflibercept in the treatment of neovascular age-related macular degeneration: 30-month results
• The nuclear factor E2-related factor 2 and age-related macular degeneration
• Fluorofenidone inhibits epithelial-mesenchymal transition in human lens epithelial cell line FHL 124: a promising therapeutic strategy against posterior capsular opacification

Click here to search